GloriousMed Technology Co., Ltd. Asset Profile

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

Year established

2015

Location

Beijing China

Primary Industry

Biotechnology

About

Established in 2015 and based in Beijing, China, GloriousMed Technology Co., Ltd. is a comprehensive big data medical platform specializing in the integration of tumor precision immunodiagnosis and treatment, which integrates production, education and research. The company build a industry-university-research service system to provide a complete set of solutions for the integration of tumor precision immunodiagnosis and treatment, including the Chinese Academy of Sciences, Chinese Academy of Medical Sciences. The company has a testing institution with 2,000 square meters that the scope of testing and diagnosis projects carried out includes medical laboratory, clinical body fluids, hematology, clinical chemistry, clinical immunization, serology, cell and molecular biology, etc. In 2017, it proposes the "Tumor Immunity Ark Project", which combines clinical phenotype data and drug efficacy follow-up data, explore the evaluation standards and evaluation system of tumor immunodiagnosis and treatment, and finally realize clinical transformation. The company provides integrated solution for precision diagnosis and treatment of tumors, relying on genetic testing technology and multi-dimensional and multi-omics testing platform. Specific solution includes urinary tumors, breast cancer, lung cancer, other solid tumors, and precision immunity. The company plans to build an academic communication platform for clinical experts, pharmaceutical companies, and basic research experts. As well as it will promote the application and registration of standard test kits for products tested in clinical research and application.

Current Investors

6 Dimensions Capital, Shiyu Capital, Hangzhou Fuzhuo Venture Capital

Request a demo to show more

Primary Industry

Biotechnology

Sub Industries

Molecular Science, Genetics & Gene Therapy, Oncology/Cancer Treatment

Website

www.gloriagene.cn

Verticals

HealthTech

Company Stage

Series B

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.